4.10Open4.10Pre Close0 Volume10 Open Interest20.00Strike Price0.00Turnover86.47%IV8.99%PremiumDec 20, 2024Expiry Date2.53Intrinsic Value100Multiplier18DDays to Expiry1.57Extrinsic Value100Contract SizeAmericanOptions Type-0.7220Delta0.0993Gamma5.78Leverage Ratio-0.0294Theta-0.0067Rho-4.17Eff Leverage0.0132Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet